Synergy of the protein farnesyltransferase inhibitor SCH66336 and cisplatin in human cancer cell lines

A. A. Adjei, J. N. Davis, L. M. Bruzek, C. Erlichman, S. H. Kaufmann

Research output: Contribution to journalArticlepeer-review

120 Scopus citations

Fingerprint

Dive into the research topics of 'Synergy of the protein farnesyltransferase inhibitor SCH66336 and cisplatin in human cancer cell lines'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology